Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PGK1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PGK1 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with Als, Breast Cancer, Cancer. Connected to 67 entities in the SciDEX knowledge graph.
| Gene Symbol | PGK1 |
| Full Name | Phosphoglycerate Kinase 1 |
| Chromosome | Xq21.1 |
| Protein Type | Enzyme |
| Function | PGK1 catalyzes the reversible conversion of 1,3-bisphosphoglycerate (1,3-BPG) to 3-phosphoglycerate (3-PG), generating ATP |
| Primary Expression | brain tissue |
| Molecular Weight | 44.6 kDa |
| Amino Acids | 417 aa |
| Pathways | Glycolysis, Mtor |
| UniProt ID | P00558 |
| NCBI Gene ID | 5230 |
| Ensembl ID | ENSG00000102144 |
| OMIM | 311800 |
| GeneCards | PGK1 |
| Human Protein Atlas | PGK1 |
| Associated Diseases | Als, Cancer, Carcinoma, Glioblastoma, Tumor |
| Known Drugs/Compounds | terazosin, Terazosin, levodopa |
| Interactions | WNT7B, YBX1, NEURODEGENERATION, PARKINSON'S DISEASE, PARKINSON, ATP |
| KG Connections | 81 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PGK1["<b>PGK1</b>"]
methylglyoxal["methylglyoxal"]
PGK1 -->|"produces"| methylglyoxal
Carcinoma{"Carcinoma"}
PGK1 -->|"associated with"| Carcinoma
Cancer{"Cancer"}
PGK1 -->|"associated with"| Cancer
Tumor{"Tumor"}
PGK1 -->|"associated with"| Tumor
PGK1 -->|"therapeutic target"| Tumor
Als{"Als"}
PGK1 -->|"therapeutic target"| Als
PGK1 -->|"therapeutic target"| Carcinoma
PGK1 -->|"therapeutic target"| Cancer
PTK2["PTK2"]
PGK1 -->|"associated with"| PTK2
Glycolysis(["Glycolysis"])
PGK1 -->|"associated with"| Glycolysis
AND["AND"]
PGK1 -->|"therapeutic target"| AND
DNA["DNA"]
PGK1 -->|"therapeutic target"| DNA
YWHAZ["YWHAZ"]
YWHAZ -->|"associated with"| PGK1
VDAC1["VDAC1"]
VDAC1 -->|"associated with"| PGK1
HNRNPA1["HNRNPA1"]
HNRNPA1 -->|"associated with"| PGK1
CANCER["CANCER"]
CANCER -->|"associated with"| PGK1
CANCER -->|"therapeutic target"| PGK1
TP53["TP53"]
TP53 -->|"therapeutic target"| PGK1
GAIN["GAIN"]
GAIN -->|"therapeutic target"| PGK1
style PGK1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| methylglyoxal | produces | protein | 0.90 |
| Hippocampal Atp Levels | regulates | biomarker | 0.85 |
| Glycolysis | activates | pathway | 0.80 |
| Tumor | activates | disease | 0.75 |
| Carcinoma | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Parkinson | expressed_in | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Als | implicated_in | disease | 0.65 |
| Glioblastoma | associated_with | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Breast Cancer | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Pancreatic Cancer | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| PTK2 | associated_with | gene | 0.60 |
| PARK7 | expressed_in | gene | 0.60 |
| BECLIN1 | regulates | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| GAPDH | regulates | gene | 0.60 |
| TKT | regulates | gene | 0.60 |
| FBP1 | regulates | gene | 0.60 |
| TP53 | regulates | gene | 0.60 |
| PDK1 | regulates | gene | 0.60 |
| ENO1 | regulates | gene | 0.60 |
| WNT7B | activates | gene | 0.60 |
| YBX1 | activates | gene | 0.60 |
| epilepsy | activates | disease | 0.60 |
| Glycolysis | associated_with | pathway | 0.60 |
| DNA | therapeutic_target | gene | 0.60 |
| Glycolysis | therapeutic_target | pathway | 0.60 |
| Wnt | therapeutic_target | pathway | 0.60 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.60 |
| PARKINSON | expressed_in | gene | 0.60 |
| DJ-1 | expressed_in | gene | 0.60 |
| Chaperone | expressed_in | pathway | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| Stem Cell | activates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOE4 | downregulates | gene | 0.90 |
| terazosin | activates | drug | 0.80 |
| Terazosin | activates | drug | 0.80 |
| YWHAZ | associated_with | gene | 0.60 |
| VDAC1 | associated_with | gene | 0.60 |
| HNRNPA1 | associated_with | gene | 0.60 |
| TP53 | therapeutic_target | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| PTEN | activates | gene | 0.60 |
| APOE4 | interacts_with | gene | 0.60 |
| APOE4 | activates | gene | 0.60 |
| levodopa | targets | drug | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| ATG14L | activates | gene | 0.60 |
| ATP | interacts_with | gene | 0.60 |
| APOE3 | activates | gene | 0.60 |
| ATP | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||